skip to content

Wellcome-MRC Cambridge Stem Cell Institute

 
CSCI welcomes new PIs

This month, CSCI welcomes two new scientists to join the group of 29 PIs conducting stem cell research in Cambridge. 

Dr Maria Duque-Correa  started her own research group at the Cambridge Institute of Therapeutic Immunology and Infectious Disease at the University of Cambridge in January 2022, and will continue her research on infectious diseases, host-pathogen interaction and immunology with her group at CSCI. 

 

Maria says, 'I am delighted to join the Cambridge Stem Cell Institute and very looking forward to collaborating with so many brilliant scientists, which are delivering cutting edge research on stem cell biology. Their expertise and the incredible facilities available at the Institute will provide exciting opportunities to further develop my research in the effects on parasitic worms on the stem cell niche compartment.'

Dr Matthias Zilbauer will be joining from the Department of Paediatrics, where his group studies human intestinal epithelial stem cell biology during development, health and related diseases such as Inflammatory Bowel Diseases (IBD) and Necrotising Enterocolitis (NEC). Dr Zilbauer was also recently honoured with a Public Engagement Award for his work with patients at the CSCI Annual Retreat. 

Dr Zilbauer says, 'We are very excited about joining CSCI and look forward to extending our collaborations with other groups/PIs.’

On welcoming these two researchers into the Institute, Director Bertie Göttgens says, 'I am delighted that Maria and Matt are joining the Institute as new group leaders, They will not only strengthen the institute's research around epithelial stem cells, but with their focus on whipworm infection and inflammatory bowel disease respectively, they will also introduce new and exciting disease models into the wider CSCI portfolio.'